Q2 2012 Results (Merrimack) - Aug 10, 2012 - Anticipated data presentation of P1 combination study for breast cancer by August
Anticipated P1 data • Breast Cancer
|
|
MM 111
---
Merrimack anticipates the following milestones in the next 12 months:
Presentation on a Phase 1 study of MM-111 in combination with multiple agents
---
(IR 4)
|